These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 2133147
1. [Postmenopausal women: changes in plasma lipids with different estrogen replacement therapies]. Blumel JE, Brandt A, Garabagno A, Cubillos M, Lozano A. Rev Med Chil; 1990 Apr; 118(4):382-7. PubMed ID: 2133147 [Abstract] [Full Text] [Related]
3. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia. Sanada M, Nakagawa H, Kodama I, Sakasita T, Ohama K. Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207 [Abstract] [Full Text] [Related]
4. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC. Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534 [Abstract] [Full Text] [Related]
5. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women. Barnes RB, Roy S, Lobo RA. Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832 [Abstract] [Full Text] [Related]
7. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women. Davidson MH, Testolin LM, Maki KC, von Duvillard S, Drennan KB. Arch Intern Med; 1997 Jun 09; 157(11):1186-92. PubMed ID: 9183229 [Abstract] [Full Text] [Related]
8. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women. Lindheim SR, Notelovitz M, Feldman EB, Larsen S, Khan FY, Lobo RA. Obstet Gynecol; 1994 Feb 09; 83(2):167-72. PubMed ID: 8290176 [Abstract] [Full Text] [Related]
13. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol]. Milewicz T, Kostecka A, Rogatko I, Sztefko K, Kwiatkowska-Panek E, Radowick S, Krzysiek J. Przegl Lek; 2007 Feb 09; 64(2):65-9. PubMed ID: 17892034 [Abstract] [Full Text] [Related]
17. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Araújo DA, Farias ML, Andrade AT. Climacteric; 2002 Sep 09; 5(3):286-92. PubMed ID: 12419087 [Abstract] [Full Text] [Related]
18. Effects of E2 and E2/norgestimate hormone therapy on elevated baseline lipids. Langer RD, Friedman AJ. J Reprod Med; 2006 Aug 09; 51(8):610-6. PubMed ID: 16967629 [Abstract] [Full Text] [Related]